Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Inclusion and exclusion criteria and primary and secondary trial outcomes matching systematic review outcomes

From: A systematic review and meta-analysis of thoracic epidural analgesia versus other analgesic techniques in patients post-oesophagectomy

Year and author

Inclusion criteria

Exclusion criteria

Primary outcomes

Secondary outcomes

Flisberg et al. 2001

ASA 1–3, thoracoabdominal oesophagectomy

NR

Nil

Pain scores at 24 and 48 h

Yokoyama et al. 2005

ASA 1–2, radical oesophagectomy, oesophageal cancer

Preoperative steroid/NSAID

Nil

Pain scores at 24 and 48 h

Fares et al. 2014

ASA 1–2, age 20–60 years, Ivor Lewis oesophagectomy

NYHA 3–4, chronic obstructive pulmonary disease, CKD, Child–Pugh B liver failure or worse, bleeding diathesis. Preoperative steroid

Pulmonary complications

Pain scores at 24 and 48 h

Liu and Wang 2015

ASA 1–2, age 40–65 years, 45–70 kg, radical oesophagectomy and thoracotomy

Preoperative radiotherapy or chemotherapy. Endocrine/metabolic diseases, antiplatelet/anticoagulant drugs. Perioperative blood transfusion

Nil

Pain scores at 24 and 48 h

Wang et al. 2017

ASA 1–2, age 18–65 years, BMI 18–30

Heart/liver/kidney/electrolyte/neuromuscular/immune/endocrine disorder. Postoperative mechanical ventilation or secondary surgery during study

Nil

Pain scores at 24 and 48 h, PONV, LOS

Wang et al. 2019

Elective radical oesophagectomy

ASA 4, preoperative opioids/NSAIDs/immunosuppressive drugs. Cardiovascular/immune/endocrine disease

Nil

Pain scores at 24 and 48 h

Li 2019

ASA 1–2, age 40–65 years, 45–80 kg, thoracoabdominal oesophagectomy, gastro-oesophageal carcinoma

Preoperative chemo/radiotherapy, cardiovascular/autoimmune/endocrine/metabolic/coagulation/kidney/liver disorder. Preoperative opioid/NSAID/blood transfusion. Postoperative mechanical ventilation

Nil

Pain scores at 24 and 48 h, PONV

Zhu et al. 2020

ASA 1–2, thoracotomy

Preoperative chemo/radiotherapy/opioid/immunosuppressant/steroid. Autoimmune/endocrine/metabolic diseases. Abnormal liver and kidney function tests. Perioperative blood transfusion

Nil

Pain scores at 24 and 48 h

Maghsoudloo et al. 2023

20–80 years, oesophagectomy

ASA 3 or higher, coagulation/severe haemodynamic/severe movement/chest/neurological disorders, substance abuse

Pulmonary complications

Pain scores at 24 and 48 h

Xu et al. 2023

 > 17 years, thoraco-laparoscopic (McKeown) oesophagectomy

Open oesophagectomy, chronic pain with opioid use, not suitable for one lung ventilation, prior lung surgery

Pulmonary complications

Pain scores at 24 and 48 h, LOS

  1. ASA American Society of Anesthesiologists physical status grade, y years, BMI body mass index, NSAID nonsteroidal anti-inflammatory drug, NYHA New York Heart Association heart failure grade, CKD chronic kidney disease, PONV postoperative nausea and vomiting, LOS length of stay in hospital